- Company Overview for AXALBION THERAPEUTICS LIMITED (13224059)
- Filing history for AXALBION THERAPEUTICS LIMITED (13224059)
- People for AXALBION THERAPEUTICS LIMITED (13224059)
- Charges for AXALBION THERAPEUTICS LIMITED (13224059)
- More for AXALBION THERAPEUTICS LIMITED (13224059)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
03 Nov 2021 | CS01 | Confirmation statement made on 3 November 2021 with updates | |
03 Jun 2021 | AA01 | Current accounting period shortened from 28 February 2022 to 31 December 2021 | |
22 Apr 2021 | PSC07 | Cessation of Ashley Arthur Woodcock as a person with significant control on 16 March 2021 | |
14 Apr 2021 | AP01 | Appointment of Michael Kitt as a director on 31 March 2021 | |
12 Apr 2021 | RESOLUTIONS |
Resolutions
|
|
03 Apr 2021 | RESOLUTIONS |
Resolutions
|
|
03 Apr 2021 | MA | Memorandum and Articles of Association | |
26 Mar 2021 | AP01 | Appointment of Paul Hartley Glyer as a director on 16 March 2021 | |
25 Mar 2021 | AP01 | Appointment of Mr Adrian Ivery Field as a director on 16 March 2021 | |
25 Mar 2021 | AP01 | Appointment of Marc-Henry Peppo Jules Rochat as a director on 16 March 2021 | |
25 Mar 2021 | SH01 |
Statement of capital following an allotment of shares on 16 March 2021
|
|
25 Mar 2021 | PSC01 | Notification of Jonathan Paul Moulton as a person with significant control on 16 March 2021 | |
25 Mar 2021 | AP01 | Appointment of Peter Vitins as a director on 16 March 2021 | |
24 Feb 2021 | NEWINC |
Incorporation
Statement of capital on 2021-02-24
|